资讯

Investing Snacks27 分钟

Merck Launches Phase 3 Trials for PrEP Therapy

Merck & Co., Inc. has kicked off two Phase 3 trials for its experimental PrEP therapy, MK-8527. **The trials, EXPrESSIVE-10 ...
Yahoo Finance10 分钟

Merck to Begin Phase 3 Trials for Investigational Monthly HIV Prevention Pill

It is one of the Best Weight Loss Stocks. While we acknowledge the potential of MRK as an investment, we believe certain AI ...